This account describes coupling reaction of 1,3-disubstituted secondary allylic carbonates with lithium aryl-and alkenylborates in the presence of a nickel catalyst. Borates examined are 4, 5, and 6, and reactivity and selectivity were investigated using the allylic carbonates 1a and 1b. Coupling of 1a,b with borates 4 was effected with the nickel catalyst, NiCl 2 (PPh 3 ) 2 or NiCl 2 (dppf), in THF at 45-65°C to provide products 3 in good yields with almost 100% regio-and stereoselectivities. Trivalent organoboranes prepared from acetylenes by hydroboration with catecholborane also underwent coupling reaction with 1a,b after transformation to borates 5 with MeLi. Though coupling using 4 and 5 required elevated temperature (45-65°C), cyclic borates 6 prepared in situ from boronates 8 and MeLi were found to couple with 1a,b at room temperature or below. Regio-and stereoselectivities were almost 100% as were observed in the cases of 4 and 5. In these reactions, palladium complexes such as Pd(PPh 3 ) 4 , Pd 2 (dba) 3 ‚CHCl 3 + 2 PPh 3 showed no catalytic activity. Stereochemical aspect of the present reaction was studied using cyclohexenyl carbonate 24 with 2-furylborate 4e and phenylborate 6a, and was found to proceed with overall anti fashion. With additional experiments, the mechanism of the present reaction was discussed in terms of transient π-allylnickel intermediates.
Substitution reactions of 1,3-disubstituted allylic carbonates 3 with aryl-and alkenyl-borates 4 are catalysed by [NiC12(dppf)] [dppf = 1 ,I '-bis(diphenylphosphino)ferrocene], and in the case of the cyclic carbonate 7, the reaction proceeds with complete inversion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.